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Increasing evidence suggests complex genetic factors for
attention-deficit/hyperactivity disorder (ADHD). Animal models
with definitive genetic characteristics are indispensable for
gaining an understanding of the molecular, cellular, and neural
circuit mechanisms underlying ADHD. Toward this aim, mice
have several advantages because of their well-controlled
genetic backgrounds and the relative ease with which functions
of defined neuronal circuits can be manipulated. Dopamine
signaling dysfunction was once the major pathogenic focus of
interest in ADHD research, but hypotheses have expanded to
include functionally distinct molecules. Forward and reverse
genetic approaches have produced diverse mouse genetic
models for genes involved in monoaminergic signaling,
synaptic plasticity, and neuronal circuit formation. Data
suggest crucial roles of gene–gene interactions and gene–
environment interactions in the pathophysiology of ADHD.
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Introduction
Attention-deficit/hyperactivity disorder (ADHD) is a
neurodevelopmental disorder defined by inattention
and/or hyperactivity-impulsivity that occurs in 5% of
children and 2.5% of adults worldwide [1]. Attention is
the ability to focus on particular (important) sensory
information and ignore other (less important) information.
Attention can be divided into subdomains comprising
alerting, orienting, and executive attention functions;
and neuroimaging data in humans suggest the existence
of broad attention networks [2]. Impulse control is
required to optimize animal actions, and is divided into
subcognitive domains potentially involving distinct
neuronal circuits and neurochemistry [3,4]. Imaging stu-
dies in ADHD indicate hypofunction and/or volume
changes in various brain regions, such as the anterior
cingulate, dorsolateral and inferior prefrontal cortices,
basal ganglia, thalamus, parietal cortex, and cerebellum
[4,5,6]. Cognitive domains for attention and impulsivity
may provide foundations of other cognitive/emotional
domains and personality [7]. Inattentive and impulsive
behaviors are also comorbid with other psychiatric dis-
orders, such as autism spectrum disorders, bipolar dis-
order, and developmental coordination disorders
[1,8,9,10]; and are a risk factor for the development of
antisocial and drug-abuse disorders [1].
Human genetics for ADHD
Family, adoption, and twin studies support the heritable
etiology of ADHD (for review see: [11]). Psychostimu-
lants, such as methylphenidate and amphetamine, potent
dopamine reuptake inhibitors, ameliorate the symptoms
of ADHD. The paradoxic effects of these agents, how-
ever, led researchers to hypothesize that abnormal dopa-
minergic signaling causes ADHD and to search for an
association between a polymorphism at the dopamine
transporter locus (DAT1) and ADHD [12]. The findings
of hypothesis-driven studies focusing on the genes
involved in catecholaminergic systems suggest various
genes potentially involved in the pathogenesis of ADHD.
Meta-analyses of the hypothesis-driven research support
significant associations of several candidate genes, in-
cluding DAT1, DRD2, DRD4, DRD5, 5HTT, HTR1B,
and SNAP25 [13,14]. These studies, however, also
revealed modest odds ratios (<1.33) for all of the signifi-
cant polymorphisms, suggesting that each gene has only a
small effect and supporting a multifactorial and polygenic
etiology of ADHD.
The polygenic etiology is further supported by hypoth-
esis-free genome-wide scan studies. These studies impli-
cate multiple loci, thus diluting the significance of the
classic candidate genes involved in catecholaminergic
signaling, and suggest the potential involvement of genes
for ‘new’ neurotransmission and cell-cell communication
systems, including T-cadherin [15]. A recent genome-wide
copy number variation study provided evidence for an
association of metabotropic glutamate receptors and
their interacting molecules with ADHD [16]. Taken
together, human genetic studies have established a com-
plex etiology of ADHD, similar to that of other psychia-
tric disorders. Thus, different types of model animals are
needed and proposed [17]. This article focuses on the
mouse genetic models.
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Mouse genetic models of ADHD
Dat1(Slc6a3)-KO/knockdown/cocaine-insensitive mice
DAT is expressed on axon terminals and regulates dopa-
mine (DA) signaling by transporting DA from the synap-
tic cleft back into the presynaptic terminal. Multiple lines
of evidence from genetic, pharmacologic, and imaging
studies suggest that DAT1 is a strong candidate gene
involved in the pathogenesis of ADHD. The behavioral
phenotypes of mutant mice generated by gene-targeting
methods support this notion. Dat1-knockout (KO) mice
exhibit hyperactivity and deficits in learning and memory
[18]. The mice also show attention deficits in an auditory
prepulse inhibition (PPI) test [19]. Hyperactivity and
PPI deficits in Dat1-KO mice are ameliorated by methyl-
phenidate [18,20]. A recent study revealed that Dat1-KO
mice with a mixed genetic background of C57BL/6J and
129Sv/J were impaired in a cliff avoidance reaction (CAR)
test based on their inability to remain on an elevated small
round platform without falling, suggesting impulsivity
[21]. Methylphenidate or nisoxetine ameliorated the cliff
avoidance reaction impairment in the Dat1-KO mice [21].
Dat1-knockdown mice also exhibited hyperactivity and
risk-taking behavior in a mouse version of the Iowa
gambling test [22], reflecting impulsivity. Dat1-knockin
mice carrying the cocaine-insensitive mutation exhibit
reduced DAT activity [23]. Although the Dat1-cocaine
insensitive mice exhibit hyperactivity, their locomotor
activity and responses to amphetamine are dependent on
their genetic background [24], suggesting a crucial role of
gene–gene interactions for these phenotypes. Other phe-
notypes relating to attention and impulsivity in these
mice have not been documented.
Drd4-KO mice
Although genes encoding DA receptors are classic candi-
dates for ADHD, experimental evidence from Drd1,
Drd2, Drd3, Drd4, and Drd5 KO mice for these genes
affecting ADHD-relevant endophenotypes is weak [25].
Interesting results were reported for Drd4-heterozygous
mice [26]. Young et al. applied a 5-choice continuous
performance test (5C-CPT), which is a modification of
the 5-choice serial reaction time test (5CSRTT) [27] that
may more closely correspond to the CPT used in humans
[28]. In the 5C-CPT, rodents must continue to respond to
signal stimuli (illumination of any 1 of 5 holes), and must
also inhibit their response to non-signal stimuli (simul-
taneous illumination of all 5 holes). Heterozygous but not
homozygous Drd4-KO mice exhibited attention deficits
in the 5C-CPT [26]. High impulsivity was also measured
by false alarms but not by premature responses. The mice
showed no deficits in PPI or spontaneous exploratory
behavior. It is plausible that the complete lack of D4
receptors leads to a robust compensatory system(s) at the
molecular and/or neural circuit levels. Interactions of
the gene with other genetic or environmental factors
require further evaluation.
COMT-KO mice
Recent works for catechol-O-methyltransferase (COMT)-
KO mice support the notion that gene–environment
interactions and gene–gene interactions are involved in
attention and impulsivity domains [29,30]. COMT
methylates and inactivates DA. In the 5CSRTT, male
and female COMT+/+, +/ and COMT / mice equally
acquire the task. Interestingly, environmental factors
induced genotype-sex interactions in the task. For
example, a mild stress (15 min exposure in an empty
cage at 800 lx before test) increased impulsive prema-
ture responses in COMT+/ and / males, but not in
females [29]. In contrast, females, but not males, exhib-
ited genotype differences in perseverative responses.
COMT/ females showed perseverative responses at a
lower rate compared to other genotypes [29]. Differen-
tial effects of various stimuli are consistent with the sex
difference in ADHD prevalence [1].
DTNBP1 (dysbindin) is a molecule that has a role in
homeostasis of excitatory synapses [31]. C57BL6/J con-
genic COMT+/ and / males and C57BL6/J congenic
Dtnbp1+/ and / males learn the T-maze working
memory task, which demands a high level of attention,
faster than wild-type mice. In contrast, double mutants
(double heterozygotes and homozygotes) learn slower
than wild-types [30]. Although Papaleo et al. [30]
did not directly examine attention and impulsive beha-
viors, their data clearly demonstrated the significance of
gene–gene interactions in behaviors requiring attention.
Interestingly, similar interactions between COMT and
DTNBP1 are observed in functional magnetic resonance
imaging analysis during working memory tasks in healthy
humans [30]. The COMT rs4680 Met allele has reduced
COMT enzyme activity compared to the Val allele, and
the ‘Bray haplotype’ of DTNBP1, carrying three markers
rs2619538–rs3213207–rs1047631, has a lower level of
mRNA expression. COMT M/M carriers show evidence
of efficient prefrontal cortical activity during the task,
but the effect is canceled by the presence of DTNBP1
Bray+/+ alleles [30].
GC-C-KO mice
Guanylyl cyclase-C (GC-C), which is a membrane receptor
for the gut peptide hormones guanylin and uroguanylin, is
selectively and strongly expressed in dopaminergic
neurons in the ventral tegmental area and substantia nigra
compacta. GC-C activation by its ligands activates meta-
botropic glutamate receptors and muscarinic acetylcholine
receptors via the activity of guanosine 30,50-monophos-
phate-dependent protein kinase [32]. GC-C-KO mice in
the C57BL6 genetic background exhibit hyperactivity in
both the home cage and novel open-field. In a Go/No-go
test using water as a reward and two distinct auditory
stimuli as Go and No-go signals, the GC-C-KO mice
showed impulsivity and attention deficits [32]. The hyper-
activity observed in the open field was ameliorated by
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systemic injection of amphetamine or infusion of a gua-
nosine 30,50-monophosphate-dependent protein kinase
agonist into the ventral tegmental area and substantia nigra
compacta [32], suggesting a crucial role for GC-C in do-
paminergic signaling. The selective expression pattern of
GC-C increases the significance of the model mouse.
5HT2C-KO mice
Some data suggest an association between polymorphisms
in the promoter region of the X-chromosome linked ser-
otonin 2c receptor (5HT2C) gene (Htr2c) and ADHD
[33,34]. 5HT2C-KO mice are impaired in the acquisition
phase of the 5CSRTT with increased omission errors [35].
During the task performance, DA release in the nucleus
accumbens is enhanced in 5HT2C-KO mice, suggesting a
role for 5HT2C in the dopaminergic system for attention
control [35]. The mice do not exhibit premature responses,
however, which is a measure of impulsivity. Acute block-
ade of 5HT2C signaling by systemic administration of the
5HT2C-selective antagonist SB242084 increases prema-
ture responses in wild-type mice in a dose-dependent
manner. The effect is almost abolished in 5HT2C-KO
mice, suggesting a role for 5HT2C in the development of
impulse-control circuits [35].
nAChR-KO mice
Local injection of nicotine into the prefrontal cortex
enhances attentional performance in the 5CSRTT [36].
A human study focusing on attention and response inhi-
bition revealed a significant association of single nucleo-
tide polymorphisms of multiple nicotinic acetylcholine
receptor (nAChR) genes with selective attention, sus-
tained attention, and impulsivity [37]. Mice lacking the
b2 subunit (b2-KO) had an increased omission rate in the
5CSRTT compared with wild-type controls, but no
difference in accuracy or impulsivity, suggesting deficits
in sustained attention. Importantly, lentiviral vector-
mediated expression of the b2 subunit in prelimbic
neurons completely restored the attention deficits,
revealing a crucial role for b2 subunit-containing hetero-
meric channels in sustained attention [38]. In contrast to
b2-KO mice, mice lacking a5 subunits (a5-KO) had
decreased accuracy, but not a decreased omission rate
in the 5CSRTT [39]. Nicotinic excitability in layer VI
pyramidal neurons is reduced in a5-KO mice and elimi-
nated in b2-KO, and muscarinic responses are enhanced
in both b2-KO and a5-KO mice [40]. Thus, the imbal-
ance of muscarinic and nicotinic excitation may in part
account for the differential attention deficits in b2-KO
and a5-KO mice [40].
a7-KO mice exhibit attention deficits and impulsivity in
the 5CSRTT, although the phenotypes could be para-
digm-dependent [41,38,42]. In an attention set-shifting
task and a working memory test with a radial arm maze,
a7-KO mice exhibit delayed procedural learning, which
may be the central problem of developmental coordination
disorders that are comorbid with ADHD [10]. Stergiakouli
et al. argued for the role of a7 subunits based on copy
number variation and genome-wide association studies
using ADHD samples [43].
Fmr1-KO mice
Fragile X syndrome (FXS), which is caused by the
mutation in the X-linked gene FMR1, is the most inher-
ited form of mental retardation and the leading cause of
autism [44]. The majority of FXS patients, particularly
boys, present with ADHD, and the ADHD symptoms
represent a significant problem for FXS patients [45].
FMR1 encodes fragile X mental retardation protein, an
RNA-binding protein that regulates protein synthesis,
and its lack in Fmr1-KO mice results in wide range of
synaptic abnormalities, possibly via metabotropic gluta-
mate receptor signaling pathways [44,46]. In the 5CSRTT,
Fmr1-KO mice exhibit an increase in inaccurate responses
and omission errors, suggesting attention deficits, and an
increase in premature responses, indicating impulsivity
[47], although conflicting observations have also been
reported [48]. It is noteworthy that these studies used mice
with different genetic backgrounds. Fmr1-KO mice
showed poor performance in an attention set-shifting task
[49]. Interestingly, a role for Gmr5 is supported by findings
from a human study [16].
ADF/n-cofilin KO mice
Actin is abundant in presynaptic and postsynaptic struc-
tures, and its dynamics have a central role in neuronal
circuit development and activity-dependent plasticity
[50,51]. Actin depolymerizing factor (ADF)/cofilin family
members have essential roles in actin dynamics. Double-
mutant mice lacking ADF globally and n-cofilin in
prefrontal excitatory neurons (named ACC mice;
ADF//n-Cofflx/flx,CamKIICre) but not single-mutant
(ADF/, global KO, or n-Cofflx/flx,CamKII-Cre, forebrain
selective conditional KO) mice, exhibit hyperlocomotion,
impulsivity, and working-memory deficits [52], a clear
example of gene-gene interactions. Hyperlocomotion is
observed in both the home cage and novel open-field.
These mice have working-memory deficits, as indicated
by an increase in the number of revisits to the maze arms in
the eight-arm radial maze and in the Y maze spontaneous
alternation test. Impulsive behavior is observed in the
elevated plus maze. While all control and single-mutant
mice remained on the maze for the entire testing period
(300 s), 89% of the ACC mice jumped off the elevated plus
maze. Both the hyperlocomotion and impulsive pheno-
types are attenuated by methylphenidate. Electron micro-
scopic analyses reveals morphologic abnormalities in
striatal excitatory synapses (reduced synapse density, larger
button and spine structures, and increased numbers of
docked vesicles) in ACC mice but not in single-mutant
mice [52]. Interestingly, blockade of glutamate trans-
mission with dizocilpine, an N-methyl-D-aspartate receptor
antagonist, attenuates hyperlocomotion of the ACC mice.
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Zimmerman et al. argued that an inhibitory and excitatory
transmission (I/E) imbalance in striatal circuits has a crucial
role in the pathogenesis of ADHD [52].
GIT1-KO, NF1-KO, and GAT1-KO mice with an I/E
imbalance
G-protein-coupled receptor kinase-interacting protein-1
(GIT1) is a GTPase-activating protein for the ADP
ribosylation factor that interacts with multiple signaling
and adaptor proteins [53,54]. A human study demon-
strated the association of an intronic SNP with ADHD
[55], although another study failed to replicate the finding
[56]. GIT1-KO mice exhibit hyperactivity and impaired
learning and memory. They also have enhanced electro-
encephalogram theta rhythms. Amphetamine normalizes
all these phenotypes, supporting the applicability of these
mice as an ADHD model, although attention deficits and
impulsivity were not directly assessed [55]. At the cellular
level, inhibitory transmission (I) but not excitatory trans-
mission (E) is attenuated at GIT1-KO synapses, leading
to an I/E imbalance [55].
Lee and Silva discussed the significance of an I/E
imbalance in ADHD together with findings in neurofi-
bromatosis type 1 (NF1)-KO mice [57]. NF1, caused by
mutations in the gene encoding neurofibromin, a p21Ras
GTPase-activating protein, is associated with ADHD
[58]. Indeed, NF1-KO mice have an I/E imbalance as
well as attention deficits in the lateralized reaction time
task [59,60].
The gamma aminobutyric acid transporter (GAT) termi-
nates the actions of GABA in the synaptic cleft. GAT
subtype 1 (GAT1) is the major isoform in the central
nervous system [61]. GAT1-KO mice are hyperactive
and exhibit deficits in spatial reference memory [61]. In
an incentive runway test, GAT1-KO mice showed
impaired attentional focusing compared to wild-type
and heterozygous mice [62]. GAT1-KO mice also exhib-
ited impulsivity in an incentive passive avoidance test
[62].
39XY*O mice
End-to-end fusion of the X and Y chromosome pseudo-
autosomal regions in the 39 XY*O mouse results in a
deletion of the ADHD candidate gene Sts (encoding
steroid sulfatase) and the autism candidate gene Asmt
(encoding acetylserotonin-0-methyltransferase) [63].
Data from comparisons between 39 XY*O males and
40 XY MF1 males, and pharmacologic manipulation of
steroid sulfatase activities consistently support the role of
steroid sulfatase in attention as assessed by 5CSRTT
[64]. Interestingly, however, 39 XY*O males exhibit
reduced premature responses in the 5CSRTT, suggesting
a lower level of impulsivity compared to 40 XY MF1
males [64]. Moreover, using a recently developed para-
digm of the stop-signal reaction time task for evaluating
behavioral inhibition and impulsivity [65], Davies et al.
demonstrated that genetic and pharmacologic inhibition
of steroid sulfatase resulted in enhanced response control
[66]. These studies provide evidence that the genetic
basis of inattention and impulsivity is dissociable, and
support the use of 39 XY*O mice as a genetic model of
ADHD without impulsivity.
BDX recombinant inbred strains
Studies with BDX recombinant inbred strains provide
strong evidence for the importance of gene–gene inter-
actions in attention and impulsivity [67,68]. Beha-
vioral phenotypes in impulsivity and attention analyzed
by the 5CSRTT and PPI tests surpass those of the
C57BL/6J and DBA/2J founders. A forward genetic
approach utilizing BDX recombinant inbred strains
led to the identification of the developmental roles of
neuregulin-3 (Nrg3) in the mouse medial prefrontal
cortex in regulating impulsive activity [68]. Nrg3-KO
mice have decreased impulsivity. Viral overexpression
of Nrg3 in the medial prefrontal cortex of wild-type mice
increases impulsivity, but does not rescue Nrg3-KO
mouse phenotypes [68]. Thus, the Nrg3 expression
level is likely crucial. Nrg-3 binds to the extracellular
domain of the ErbB4 receptor tyrosine kinase [69], and
is likely associated with attention deficits in humans
[70].
Conclusion
ADHD mouse genetic models have become substan-
tially diversified, reflecting the progress in human
genetics and supporting the notion that ADHD has a
polygenic nature. Further efforts are needed to establish
novel genetic models. For example, some representative
genes, such as T-cadherin and metabotropic glutamate re-
ceptor 5, which are strongly supported by human genetic
studies, have not been experimentally evaluated. Data
from BDX recombinant inbred strains clearly indicate
the importance of gene-gene interactions. Neuronal
mechanisms for attention and impulse control domains
are complex and are supported by large neuronal net-
works. Behavioral phenotypes of current mouse models
have been analyzed to different extents, and available
tests for assessing attention and impulsivity remain
suboptimal. Future studies of mouse models using
refined behavioral tests and careful examination of cir-
cuit activities will enhance our understanding of the
circuit mechanisms underlying attention and impulsiv-
ity. Toward this aim, it is important to use spatially and
temporally conditioned genetic models for dissecting
selective circuits in these cognitive domains. Mice have
many advantages as tools to progress the studies of
gene–gene interactions, gene–environment interactions,
and circuit-behavior links. The relative ease of applying
optical imaging in mouse models is another advantage
for determining the circuit mechanisms underlying
ADHD.
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